Eroglu et al. [20] observed no difference between PCa patient and control groups in terms of oxidative stress parameters and lipid parameters, although PON1 enzyme activity and LDL levels in PCa patients were higher/lower? The gene discussed is PON1; the disease is posterior cortical atrophy.